In addition to the role of NLRP3, AIM2 has been suggested to play a role in the pathogenesis of type 2 diabetes (T2D) as its expression levels were reported to be upregulated in patients with T2D compared to healthy controls. This evidence concerns the gene NLRP3 and type 2 diabetes mellitus.